[Multinodular hepatopathy]

Rev Med Interne. 2002 Mar;23(3):332-3. doi: 10.1016/s0248-8663(01)00560-4.
[Article in French]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biopsy
  • Bleomycin / therapeutic use
  • Child
  • Child, Preschool
  • Cyclophosphamide / therapeutic use
  • Doxorubicin / therapeutic use
  • Female
  • Follow-Up Studies
  • Humans
  • Liver / pathology
  • Liver Neoplasms* / diagnosis
  • Liver Neoplasms* / diagnostic imaging
  • Liver Neoplasms* / drug therapy
  • Liver Neoplasms* / epidemiology
  • Liver Neoplasms* / pathology
  • Lymphoma, Large B-Cell, Diffuse* / diagnosis
  • Lymphoma, Large B-Cell, Diffuse* / diagnostic imaging
  • Lymphoma, Large B-Cell, Diffuse* / drug therapy
  • Lymphoma, Large B-Cell, Diffuse* / epidemiology
  • Lymphoma, Large B-Cell, Diffuse* / pathology
  • Male
  • Middle Aged
  • Prednisone / therapeutic use
  • Prognosis
  • Sex Factors
  • Time Factors
  • Ultrasonography
  • Vindesine / therapeutic use

Substances

  • Bleomycin
  • Doxorubicin
  • Cyclophosphamide
  • Vindesine
  • Prednisone

Supplementary concepts

  • LNH 87 protocol